menu search

DRTS / Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day

Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day
JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that Raphi Levy, Chief Financial Officer, will take part in a fireside chat at the Guggenheim Radiopharmaceuticals Day in New York City on Monday, May 15th, 2023. Read More
Posted: May 3 2023, 16:00
Author Name: GlobeNewsWire
Views: 112533

DRTS News  

Should You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?

By Zacks Investment Research
May 22, 2023

Should You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?

Alpha Tau Medical (DRTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal

Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day

By GlobeNewsWire
May 3, 2023

Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day

JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the inn more_horizontal

Alpha Tau: Treating Cancer With Precision Alpha Radiation

By Seeking Alpha
April 12, 2022

Alpha Tau: Treating Cancer With Precision Alpha Radiation

Alpha Tau: Treating Cancer With Precision Alpha Radiation more_horizontal


Search within

Pages Search Results: